Vanda Pharmaceuticals Inc Q3 2024 Earnings Call Highlights Revenue Surge Amidst Rising ...

VNDA Stock  USD 4.85  0.03  0.62%   
About 52% of Vanda Pharmaceuticals' investor base is interested to short. The analysis of the overall investor sentiment regarding Vanda Pharmaceuticals suggests that many traders are impartial. The current market sentiment, together with Vanda Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Vanda Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Vanda Pharmaceuticals Inc reports a 23 percent revenue increase in Q3 2024, driven by Fanapt sales, despite a net loss and increased operating expenses.

Read at finance.yahoo.com
Yahoo News
  

Vanda Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Vanda Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Vanda Pharmaceuticals Fundamental Analysis

We analyze Vanda Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vanda Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vanda Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Vanda Pharmaceuticals is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Vanda Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vanda Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Vanda Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Vanda Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Vanda Pharmaceuticals Related Equities

NUVBNuvation Bio   11.58   
0%
100.0%
PHATPhathom Pharmaceuticals   5.59   
0%
48.0%
KZRKezar Life   4.41   
0%
38.0%
TECHBio Techne   3.23   
0%
27.0%
LEGNLegend Biotech   3.02   
0%
26.0%
RLAYRelay Therapeutics   2.79   
0%
24.0%
CGEMCullinan Oncology   2.34   
0%
20.0%
STOKStoke Therapeutics   1.95   
0%
16.0%
PCVXVaxcyte   1.87   
0%
16.0%
LQDALiquidia Technologies   1.57   
0%
13.0%
BPMCBlueprint Medicines   1.32   
0%
11.0%
CYTKCytokinetics   0.88   
0%
7.0%
BMRNBiomarin Pharmaceutical   0.51   
0%
4.0%
REPLReplimune   0.48   
0%
4.0%
RVMDRevolution Medicines   0.27   
0%
2.0%
RCUSArcus Biosciences   0.46   
3.0%
0%
GPCRStructure Therapeutics   1.53   
13.0%
0%
ANNXAnnexon   1.64   
14.0%
0%
TSVT2Seventy Bio   1.69   
14.0%
0%
CNTBConnect Biopharma   2.48   
21.0%
0%
TILInstil Bio   4.67   
40.0%
0%

Complementary Tools for Vanda Stock analysis

When running Vanda Pharmaceuticals' price analysis, check to measure Vanda Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vanda Pharmaceuticals is operating at the current time. Most of Vanda Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vanda Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vanda Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vanda Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets